Notas de Prensa Netwrix Security Research Lab Forecasts 2026-2029: The Rise of Identity and Data Security DependencySkyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's DiseaseSaber Integrates with Circle Payments Network to Strengthen Global Off-Ramp CapabilitiesBrowserStack Launches Accessibility DevTools to Shift Left Accessibility Testing into IDEDMEGC Solar impulsa la transición a la energía solar del mayor hospital localSkyhawk Therapeutics anuncia resultados de su ensayo clínico de SKY-0515 para la enfermedad de HuntingtonSkyhawk Therapeutics anuncia resultados provisionales de nueve meses en pacientes de su ensayo clínico de fase 1 de SKY-0515 como tratamiento para la enfermedad de HuntingtonCapital Gearing Trust P.l.c. - Net Asset Value(s)Phemex Introduces Elite Trader Recruitment Program Focused on Professional Copy TradingRoboMarkets expands access to over 1,400 XETRA-traded stocks and ETFs«2026-01-252026-01-262026-01-27«1234567»2026-01-282026-01-29»
Fondos de Inversion 
